From Home Sleep Testing to In-Lab PSG: How Australian Sleep Labs Unify Multi-Channel Study Types in a Single Software Platform

From Home Sleep Testing to In-Lab PSG: How Australian Sleep Labs Unify Multi-Channel Study Types in a Single Software Platform

Australian sleep labs are increasingly expected to manage a diverse mix of study types, from Level 1 in-lab polysomnography (PSG) to home sleep apnea tests (HSAT), within a single operational workflow. The core challenge is not the technology itself, but the software infrastructure required to unify these different data streams, reporting formats, and clinical workflows without creating silos. A unified platform approach, where all study types feed into one reporting and management system, is fast becoming the operational standard for high-performing sleep labs in Australia.

TL;DR

  • Sleep labs now routinely manage both in-lab PSG and home-based studies, creating a multi-channel data problem.

  • Research suggests home sleep testing can be diagnostically accurate for OSA, but clinician oversight remains critical for quality outcomes.

  • The biggest operational risk is fragmented software, not fragmented devices.

  • A vendor-neutral, cloud-based platform allows labs to integrate any device from any manufacturer into a single workflow.

  • Rezibase is built specifically for this challenge, covering both respiratory and sleep under one platform.

What Is the Difference Between In-Lab PSG and Home Sleep Testing?

In-lab polysomnography (PSG) is the gold standard for sleep diagnostics. It is a Level 1, attended study conducted in a clinical environment, capturing comprehensive physiological data including EEG, EOG, EMG, respiratory effort, airflow, oxygen saturation, and cardiac activity.

Home sleep apnea testing (HSAT) covers Level 2 to Level 4 devices, ranging from full unattended PSG-equivalent devices to simpler oximetry-based tools. These are conducted in the patient's own home without direct technician supervision.

Feature

In-Lab PSG (Level 1)

Home Sleep Testing (Level 2-4)

Supervision

Attended

Unattended

Channels recorded

Full (EEG, EMG, EOG, etc.)

Reduced (device-dependent)

Setting

Clinical lab

Patient's home

Best for

Complex cases, children, comorbidities

Suspected uncomplicated OSA in adults

Data volume

High

Moderate to low

The distinction matters operationally because each study type generates different data formats, requires different reporting templates, and carries different clinical review requirements.

Why Is Managing Multiple Study Types a Software Problem?

The proliferation of study types is not a clinical problem in isolation. It is fundamentally a data management and workflow problem.

When a lab runs in-lab PSG studies alongside home sleep tests from two or three different device manufacturers, the result is often:

  • Multiple disconnected software systems, each tied to a specific device brand

  • Manual re-entry of results into a central reporting system

  • Inconsistent report formats across study types

  • Difficulty tracking patient journeys that span both home and in-lab studies

  • Accreditation risk from poor audit trails and inconsistent documentation

This is vendor lock-in in practice. A lab that purchases a new HSAT device is effectively forced to adopt that manufacturer's reporting software, adding another silo to an already fragmented environment.

What Does the Research Say About Home Sleep Testing Accuracy?

The clinical case for home sleep testing is well-established for adult OSA, though with important caveats around oversight and patient selection.

A review published in the Canadian Journal of Health Technologies found that Level 2 PSG may have moderate accuracy compared to Level 1 PSG for diagnosing obstructive sleep apnea, though the authors noted the conclusion was based on a study with limitations. This is a useful reminder that home testing is not a blanket replacement for in-lab studies.

Research published in the Journal of Clinical Sleep Medicine examining home sleep testing in children found that HSAT devices could correctly identify OSA status in some cases, but the authors raised important questions about whether home testing should be routinely applied in pediatric populations given the complexity of childhood sleep disorders.

Critically, a study published in Frontiers in Neurology found that sleep medicine practitioner review of home study results significantly decreased the need for repeat testing with formal in-lab PSG. This finding reinforces a core principle: the device is only part of the equation. Clinician input on home study results directly improves diagnostic efficiency and patient outcomes.

The takeaway for labs is that home sleep testing expands access and throughput, but it does not reduce the need for expert clinical oversight. That oversight needs to be supported by software that makes review fast, structured, and auditable.

What Does a Hybrid Sleep Lab Model Look Like in Practice?

A hybrid sleep lab model combines the accessibility of home testing with the clinical depth of in-lab PSG, routing patients to the appropriate study type based on clinical criteria.

According to SleepWorld Magazine, state-of-the-art diagnostics are now allowing labs to bring the sleep laboratory directly to the patient's home with self-applied Type II PSG testing, while in-lab expertise remains available for complex cases. The future, as the article describes it, is hybrid.

In a well-functioning hybrid model:

  1. A referral arrives and is triaged based on clinical criteria (age, comorbidities, suspected diagnosis).

  2. Straightforward adult OSA cases are allocated to home sleep testing.

  3. Complex cases, pediatric patients, or those requiring CPAP titration are scheduled for in-lab PSG.

  4. Results from both pathways feed into the same reporting platform.

  5. Clinicians review and sign off reports from a single interface.

  6. Billing, accreditation records, and patient history are all maintained in one place.

The failure point in most labs is step four. Without a unified platform, steps four through six require manual intervention, creating inefficiency and clinical risk.

How Does Rezibase Support Multi-Channel Sleep Lab Workflows?

Rezibase is a cloud-based sleep and respiratory reporting platform built by respiratory scientists, specifically designed to handle the kind of multi-channel, multi-device complexity that modern Australian sleep labs face.

Its vendor-neutral architecture means it is not tied to any single device manufacturer. Labs can import data from any HSAT device or PSG system using the Magic Import function, which automatically extracts discrete data without manual re-entry. This directly addresses the fragmentation problem that arises when labs run multiple study types across different device brands.

Key capabilities relevant to hybrid sleep lab operations include:

  • Unified reporting across study types: In-lab PSG and home sleep study results are managed within the same platform, with consistent report structures.

  • AI-assisted report writing: Reduces reporting time and supports structured, guideline-aligned documentation.

  • Accreditation support: Built-in tools for TSANZ/NATA standards compliance, including document management, audit trails, and quality control.

  • Full admin workflow: From referral intake and waitlist management through to billing, all within one system.

  • Cloud-based access: Clinicians and scientists can review and report from any location, supporting both on-site and remote review workflows.

For labs transitioning from an existing system such as Respiro, Rezibase supports a straightforward data migration process. The transition is designed to be low-friction, with the Rezibase team managing the technical side so that lab staff can focus on patient care rather than IT complexity.

Frequently Asked Questions

Can Rezibase handle both home sleep testing and in-lab PSG in the same system?
Yes. Rezibase is designed to manage multiple study types within a single platform, regardless of the device manufacturer used to conduct the study.

Does home sleep testing replace in-lab PSG?
No. Home sleep testing is appropriate for specific patient populations, primarily adults with suspected uncomplicated OSA. In-lab PSG remains the standard for complex cases, pediatric patients, and CPAP titration studies.

Is clinician review still required for home sleep studies?
Research published in Frontiers in Neurology found that clinician review of home study results reduced the need for repeat in-lab testing. Clinical oversight remains an important part of the diagnostic pathway regardless of where the study is conducted.

How difficult is it to migrate data from an existing system to Rezibase?
Data migration is managed by the Rezibase team and is designed to be straightforward. Labs do not need to manage the technical process themselves.

Is Rezibase only for large hospitals?
No. Rezibase serves both public hospital labs and private respiratory and sleep clinics across Australia, New Zealand, the UK, and Ireland.

Does Rezibase support accreditation requirements?
Yes. The platform includes a dedicated accreditation module covering TSANZ/NATA and ISO 15189 requirements, including document management, non-conformance tracking, and quality control.

What makes Rezibase different from a device manufacturer's own software?
Rezibase is manufacturer-agnostic and not tied to any single device brand. Labs can use equipment from any vendor and manage all results within one platform, avoiding vendor lock-in.

About Rezibase

Rezibase is Australia's most advanced cloud-based respiratory and sleep reporting platform, trusted by over 35 sites including NSW Health and the NHS in the UK. Built by respiratory scientists and backed by Cardiobase, Rezibase covers the full workflow from referral to billing across both respiratory and sleep, with no vendor lock-in and no long-term contracts.

Explore how Rezibase can unify your sleep lab's workflows at rezibase.com.

References

The Complete Guide to Sleep Study Data Sovereignty in Australia: Why Local Cloud Hosting Matters for Polysomnography Reporting ›

The Complete Guide to Sleep Study Data Sovereignty in Australia: Why Local Cloud Hosting Matters for Polysomnography Reporting ›